Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chamaiphorn Wongwan"'
Autor:
Kittiporn, Punuch, Chamaiphorn, Wongwan, Saranrat, Jantana, Chayapol, Somboonyosdech, Kamonlatth, Rodponthukwaji, Natsuda, Kunwong, Kytai T, Nguyen, Vorapan, Sirivatanauksorn, Yongyut, Sirivatanauksorn, Chatchawan, Srisawat, Primana, Punnakitikashem
Publikováno v:
International journal of molecular sciences. 23(20)
Angiogenesis inhibitor drugs have been explored as important pharmacological agents for cancer therapy, including hepatocellular carcinoma. These agents have several drawbacks, such as drug resistance, nonspecific toxicity, and systemic side effects.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9241fde7898d4b22084d12427b8a7816
https://pubmed.ncbi.nlm.nih.gov/36293521
https://pubmed.ncbi.nlm.nih.gov/36293521
Autor:
Kytai T. Nguyen, Chayapol Somboonyosdech, Theeraphong Pho-iam, Vorapan Sirivatanauksorn, Sirinapa Sripinitchai, Primana Punnakitikashem, Chatchawan Srisawat, Yongyut Sirivatanauksorn, Chamaiphorn Wongwan, Patarabutr Masaratana
Publikováno v:
Biochemical and Biophysical Research Communications. 553:191-197
Hepatocellular carcinoma (HCC) is one of the most common cancers and is a leading cause of death. Delivery of therapeutic molecules, e.g., siRNA, to HCC cells could potentially be an alternative treatment for HCC. In this study, the siRNA targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75bf415b6bc39a245de1a0b1979aa3e2
https://doi.org/10.1016/j.bbrc.2021.03.086
https://doi.org/10.1016/j.bbrc.2021.03.086
Autor:
Kittiporn Punuch, Chamaiphorn Wongwan, Saranrat Jantana, Chayapol Somboonyosdech, Kamonlatth Rodponthukwaji, Natsuda Kunwong, Kytai T. Nguyen, Vorapan Sirivatanauksorn, Yongyut Sirivatanauksorn, Chatchawan Srisawat, Primana Punnakitikashem
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12666
Angiogenesis inhibitor drugs have been explored as important pharmacological agents for cancer therapy, including hepatocellular carcinoma. These agents have several drawbacks, such as drug resistance, nonspecific toxicity, and systemic side effects.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e2ba96c929f18822516ca35a84b2727
https://doi.org/10.3390/ijms232012666
https://doi.org/10.3390/ijms232012666